Reuters logo
BRIEF-Oncodesign: positive results open way for ALK1 Program to advance to lead optimization phase
November 15, 2017 / 5:21 PM / a month ago

BRIEF-Oncodesign: positive results open way for ALK1 Program to advance to lead optimization phase

Nov 15 (Reuters) - ONCODESIGN SA:

* ONCODESIGN ANNOUNCES POSITIVE RESULTS OPENING THE WAY FOR THE ALK1 PROGRAM TO ADVANCE TO THE LEAD OPTIMIZATION PHASE

* ‍ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK1) IS A TARGET INVOLVED IN ANGIOGENESIS WITH PROMISING APPLICATIONS IN CANCER THERAPIES​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below